Global Computer Aided Detection Market Size, Share, and COVID-19 Impact Analysis, By Imaging Modalities (X-Ray Imaging, Computing Tomography, Ultrasound Imaging, Tomosynthesis, and Nuclear Imaging), By Application (Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological Cancer), By End User (Hospitals, Diagnostic Centers, Research Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Computer Aided Detection Market Insights Forecasts to 2035

• The Global Computer Aided Detection Market Size Was Estimated at USD 934.7 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.38% from 2025 to 2035
• The Worldwide Computer Aided Detection Market Size is Expected to Reach USD 1663.2 Million by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

 

According to a research report published by Spherical Insights and Consulting, the global computer aided detection market size was worth around USD 934.7 million in 2024 and is predicted to grow to around USD 1663.2 million by 2035 with a compound annual growth rate (CAGR) of 5.38% from 2025 to 2035. Global integration of artificial intelligence and machine learning, improved 3D imaging, digital radiography, and cloud-based solutions that improve speed, workflow efficiency, and remote accessibility are all driving opportunities in the computer aided detection market.  

 

Market Overview

The global industry segment devoted to development, production, and deployment of software algorithms and AI-enabled systems that assist healthcare professionals especially radiologists, in analyzing medical images to detect abnormalities, thereby improving diagnostic accuracy and early disease detection, is known as the computer aided detection market. These include artificial intelligence, machine learning, and 3D imaging that enhance detection accuracy, automate image analysis, and integrate with electronic health records for better clinical workflows. Government initiatives play a critical role in promoting the market by funding digital healthcare infrastructure, supporting AI adoption, launching national screening programs, and encouraging early diagnosis through public health policies and partnerships. For instance, in February 2026, India’s 7100 patients benefited across 38 facilities under India’s first AI-based community screening program, showing direct government deployment of AI/CAD in real-world screening programs.

In January 2025, the U.S. FDA continues expanding regulatory frameworks for AI-based medical devices, including CAD systems, under its AI/ML Software as a Medical Device program, demonstrating strong regulatory support and faster approvals for AI imaging tools. The quick speed of technological advancement is one of the main drivers of the computer aided detection market's expansion.

 

Report Coverage

This research report categorizes the computer aided detection market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the computer aided detection market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the computer aided detection market.  

 

Driving Factors

Rapid technological innovation is one of the main drivers of the computer aided detection market's growth. Increasing disease burden, increasing volume of imaging procedures, and growing demand for efficient diagnostic solutions are the main factors driving the market for computer aided detection. In this field, innovation and investment are driven by the expansion of digital healthcare infrastructure, wider deployment of CAD solutions across hospitals and diagnostic centers, combined with increasing investments from private players, collaborations between technology companies and healthcare providers, and continuous product innovation. Also, strong government support is significantly accelerating the global adoption and growth of CAD technologies across radiology and diagnostic imaging.

 In February 2026, the Ministry of Health and Family Welfare launched SAHI (Strategy for AI in Healthcare for India) and BODH (Benchmarking Open Data Platform for Health AI). These initiatives create a national framework to develop, validate, and deploy AI-based diagnostic tools, including CAD systems in radiology and disease detection.

 

Restraining Factors

High development and deployment costs, concerns around diagnostic accuracy, data privacy and cybersecurity risks, lack of standardized protocols, uncertainty in clinical decision-making, and limited availability of high-quality annotated datasets for training AI models are the main factors restricting the computer-aided detection market.

 

Market Segmentation

The computer aided detection market share is classified into imaging modalities, applications, and end users.  

• The X-ray imaging segment dominated the market in 2024, approximately 40%, and is projected to grow at a substantial CAGR during the forecast period.

Based on the imaging modalities, the computer aided detection market is divided into X-ray imaging, computed tomography, ultrasound imaging, tomosynthesis, and nuclear imaging. Among these, the X-ray imaging segment dominated the market in 2024, approximately 40%, and is projected to grow at a substantial CAGR during the forecast period. High volume use in screening, cost effectiveness, early integration of AI for breast and lung cancer diagnostics, and well-established digital systems are driving the X-ray imaging industry.

 

• The breast cancer segment accounted for the largest share in 2024, approximately 67%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the computer aided detection market is divided into breast cancer, lung cancer, colon cancer, prostate cancer, liver cancer, bone cancer, and neurological cancer. Among these, the breast cancer segment accounted for the largest share in 2024, approximately 67%, and is anticipated to grow at a significant CAGR during the forecast period. High prevalence of breast cancer, widespread government-mandated screening programs, advanced imaging integration, and increased focus on early diagnosis with improved patient survival rates are driving the breast cancer industry.

 

• The hospitals segment accounted for the highest market revenue in 2024, approximately 58%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the computer aided detection market is divided into hospitals, diagnostic centers, research centers, and others. Among these, the hospitals segment accounted for the highest market revenue in 2024, approximately 58%, and is anticipated to grow at a significant CAGR during the forecast period. Increased patient volumes requiring imaging, advanced infrastructure for integrating AI-based tools, and the need for high accuracy diagnostics services for cancer screening to decrease false positives is bolstering the hospital market.  

 

Regional Segment Analysis of the Computer Aided Detection Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the computer aided detection market over the predicted timeframe.

North America is anticipated to hold the largest share of the computer aided detection market over the predicted timeframe. Strong government backing for advanced healthcare infrastructure, high adoption of AI and machine learning technologies in medical imaging, and widespread availability of sophisticated diagnostic equipment such as X-ray, CT, and MRI systems are what propel North America. The region's position is further reinforced by government programs promoting deployment of CAD solution and early and accurate detection technologies for chronic diseases.

 

Government initiatives are accelerating innovation in AI and CAD technologies. Pan-Canadian Artificial Intelligence Strategy focuses on commercialization, standards, talent development, and research. Meanwhile, the U.S. Food and Drug Administration has approved a growing number of AI-enabled medical devices as of November 2024, particularly in radiology and diagnostic imaging, including CAD tools. In September 2022, the FDA also issued guidance for CAD devices used in radiology imaging, outlining regulatory expectations for safety, performance, and clinical validation.

 

Asia Pacific is expected to grow at a rapid CAGR in the computer aided detection market during the forecast period. China, India, Japan, and South Korea are among the nations making significant investments in advanced technologies like artificial intelligence and machine learning for early disease detection. The demand for sophisticated CAD is further accelerated by the region's major centers for healthcare infrastructure and diagnostic imaging facilities. Government also supports for expanding healthcare spending, rising adoption of digital health solutions, and increasing presence of international medical technology vendors in emerging markets.

 

Government initiatives are also advancing AI and CAD adoption in healthcare. In October 2025, Central Drugs Standard Control Organization published a Draft Guidance Document on Medical Device Software, explicitly referencing CAD-based software designed to analyze X-ray images and ECGs. Meanwhile, in June 2025, National Health Commission announced plans to widely adopt AI across the healthcare system, including medical imaging analysis and clinical decision support in hospitals nationwide by 2027.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the computer aided detection market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

 

• Siemens Healthineers AG
• GE HealthCare Technologies Inc.
• KoninKlijke Philips N.V.
• Hologic, Inc.
• Fujifilm Holdings Corporation
• iCAD, Inc.
• Canon Medical Systems Corporation
• Agfa-Gevaert Group
• Carestream Health, Inc.
• Lunit Inc.
• Riverain Technologies
• EDDA Technology, Inc.
• Zebra Medical Vision
• Median Technologies S.A.
• Qure.ai
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In March 2026, Perimeter Medical Imaging AI received approval from the U.S. Food and Drug Administration for its Claire system. The company announced that this AI-enabled imaging device is the first approved for intraoperative breast cancer margin assessment, marking a significant milestone in AI-assisted detection during surgery. A nationwide rollout is planned following approval.

• In December 2025, Rad AI announced a next-generation AI-powered speech recognition module designed to enhance radiology reporting speed and accuracy, improving diagnostic workflow efficiency.

• In September 2025, Olympus Corporation announced the commercial launch of its OLYSENSE CAD/AI portfolio, a suite of AI-powered computer-aided detection applications aimed at helping clinicians identify gastrointestinal lesions and improve diagnostic outcomes.

• In February 2025, DeepHealth introduced AI-powered radiology informatics and population screening solutions, including SmartMammo and broader diagnostic SaaS systems, showcasing advanced CAD-related tools at the European Congress of Radiology.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the computer aided detection market based on the below-mentioned segments: 

Global Computer Aided Detection Market, By Imaging Modalities

 

• X-Ray Imaging
• Computed Tomography
• Ultrasound Imaging
• Tomosynthesis
• Nuclear Imaging

 

Global Computer Aided Detection Market, By Application

 

• Breast Cancer
• Lung Cancer
• Colon Cancer
• Prostate Cancer
• Liver Cancer
• Bone Cancer
• Neurological Cancer

 

Global Computer Aided Detection Market, By End User

 

• Hospitals
• Diagnostic Centers
• Research Centers
• Others

 

Global Computer Aided Detection Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia